Allspring Emerging Growth Fund Q1 2026 Performance Review

The article highlights three positive operating trends: Modine beat expectations on surging data center demand, Carpenter Technology is benefiting from higher Boeing production and regulatory approvals, and Genius Sports stands to gain from U.S. sports betting expansion and margin improvement. The overall tone is constructive, with better profitability and raised guidance driving the move. These are stock-specific catalysts that could support further gains in the names mentioned.

Analysis

The common thread is not “better earnings” but operating leverage in constrained niches: data-center thermal spending, aerospace capacity normalization, and sports-betting adtech monetization. That matters because each business has a different buyer, but all three are exposed to a similar second-order effect: when end-demand is strong enough to force customers to prioritize supply, pricing and mix improve faster than consensus models usually allow. The market is still underestimating how long these tighter supply/demand balances can persist once capex, certification, and production bottlenecks create a multi-quarter lag.

The cleanest asymmetry is likely CRS: aerospace value chains tend to re-rate slowly, but once OEM output steps up, downstream material suppliers can see a longer-than-expected earnings runway because qualification barriers protect margins even when volumes normalize. The risk is that this becomes a “good-news already priced” trade if Boeing output stabilizes but does not accelerate again; the real downside would come from any new production hiccup or an inventory digestion phase at tier-one customers, which would hit cyclical names before headline aerospace data rolls over.

GENI is more interesting as a margin story than a top-line story. The market often extrapolates sportsbook handle growth, but the larger lever is the increasing value of proprietary media and data distribution as operators push for more efficient customer acquisition; that can lift take rates and gross margin even if betting volumes are choppy. The contrarian risk is regulatory noise: if legalization momentum slows or promotional intensity in U.S. betting stays elevated, the path to durable EBITDA expansion could be delayed by 2-4 quarters, which would compress multiple expansion even if revenue grows.

The broader setup favors buying strength only where guidance inflects with structural scarcity, not just cyclical recovery. Modine-like data-center beneficiaries can keep outperforming as long as AI capex remains crowded, but the second-order risk is multiple compression if the market begins treating thermal management as a crowded trade. For that reason, relative-value expressions should prioritize the cleanest fundamental acceleration versus the most stretched expectations.

Key Decisions for Investors

• Long CRS on a 3-6 month horizon: buy on modest pullbacks or post-digestion weakness; target a 15-20% upside if aerospace production rates keep stepping up, with a 7-10% stop if Boeing-related momentum stalls.
• Pair trade: long CRS / short a more economically sensitive industrial cyclicals basket over 1-2 quarters; thesis is that qualification barriers protect CRS margins better than generic industrial exposure if growth cools.
• Long GENI into regulatory or league-partnership catalysts over the next 6-12 months; use call spreads to cap downside because the equity can re-rate quickly if margin expansion becomes visible, but execution delays can keep the stock range-bound.
• Fade crowded data-center winners only via pairs, not outright shorts: short the most extended thermal-management name against a cheaper industrial where guidance is less consensual, because the upside remains real but multiple risk is now meaningful.
• For BA knock-on exposure, prefer suppliers over BA equity outright; if you want aerospace beta, buy upstream names with pricing power and avoid direct OEM exposure until output consistency is confirmed for at least 2-3 quarters.